Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

 

2022
25:40

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

2022 Cleveland Clinic Updates on the Management of HR+ Breast Cancer

FEATURING Megan Kruse
  • 203 views
  • March 9, 2022
23:53

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

2022 Updates on Breast Cancer Disparities

FEATURING Tiffany Onger
  • 54 views
  • March 9, 2022
24:42

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

Cleveland Clinic's Breast Cancer Radiation Therapy Highlights

FEATURING Janice Lyons
  • 93 views
  • March 9, 2022
  • 1
22:14

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

2022 Cleveland Clinic Updates on IO in TNBC

FEATURING Alberto Montero
  • 57 views
  • March 9, 2022
19:41

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

Cleveland Clinic's Breast Cancer Updates Panel Discussion: TNBC, HR+, Radiation, Disparities

FEATURING Thomas Budd, Megan Kruse, Tiffany Onger, Janice Lyons, Alberto Montero
  • 46 views
  • March 9, 2022
  • 1
21:35

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

2022 Cleveland Clinic Updates in Breast Cancer Surgery

FEATURING Julie Lang
  • 209 views
  • March 9, 2022
  • 1
21:02

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

2022 Highlights in Breast Cancer Biomarkers, Predictive & Prognostic Models, and Innovation

FEATURING Hannah Gilmore
  • 238 views
  • March 9, 2022
29:10

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

2022 Cleveland Clinic Updates on the Biology and Treatment of HER2+ Breast Cancer

FEATURING Erin Roesch
  • 197 views
  • March 9, 2022
  • 2
16:44

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

Cleveland Clinic's Breast Cancer Updates Panel Discussion: HER2+, Surgical Therapies, Biomarkers

FEATURING Thomas Budd, Julie Lang, Hannah Gilmore, Erin Roesch
  • 292 views
  • March 9, 2022
  • 3